NCT05969860 At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer Status RECRUITING Phase PHASE2
NCT05965115 The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study Status RECRUITING Phase N/A
NCT05961215 Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma Status COMPLETED Phase NA
NCT05956457 PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma Status RECRUITING Phase NA
NCT05954780 Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05947136 PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70. Status RECRUITING Phase NA
NCT05945524 Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination Status RECRUITING Phase NA
NCT05932290 A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma Status COMPLETED Phase N/A
NCT05922501 Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma Status RECRUITING Phase PHASE2
NCT05911321 Isa-Pom-Dex in Elderly/Frail Subjects With RRMM Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05908396 Evaluation of IGM-2644 in Adults With Relapsed and/or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1
NCT05900882 SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease Status RECRUITING Phase PHASE2
NCT05896774 A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China Status COMPLETED Phase PHASE1
NCT05892393 Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma Status RECRUITING Phase PHASE1
NCT05889221 Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase NA
NCT05888636 Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma Status RECRUITING Phase N/A